Tay-Sachs disease screening and diagnosis: evolving technologies
- PMID: 8397824
- DOI: 10.1089/dna.1993.12.651
Tay-Sachs disease screening and diagnosis: evolving technologies
Abstract
Tay-Sachs disease (TSD) is an autosomal recessive, progressive, and fatal neurodegenerative disorder. Within the last 25 years, the discovery of the enzymatic basis of the disease, the deficiency of the enzyme hexosaminidase A, has made possible both enzymatic diagnosis of TSD and heterozygote identification. TSD is the first genetic condition for which a community-based heterozygote screening program was attempted with the intention of reducing the incidence of a genetic disease. In this article we review the clinical, biochemical, and molecular features of TSD as well as the development of laboratory technology that has been deployed in community genetic screening programs. We describe the assay procedures used and some of the limitations in their accuracy. We consider the impact of DNA-based technology on the process of identification of individuals carrying mutant genes associated with TSD and we discuss the social context within which genetic screening occurs.
Similar articles
-
Tay-Sachs disease carrier screening: a model for prevention of genetic disease.Genet Test. 1998;2(4):271-92. doi: 10.1089/gte.1998.2.271. Genet Test. 1998. PMID: 10464605 Review.
-
Molecular basis of hexosaminidase A deficiency and pseudodeficiency in the Berks County Pennsylvania Dutch.Hum Mutat. 1992;1(4):298-302. doi: 10.1002/humu.1380010406. Hum Mutat. 1992. PMID: 1301937
-
A mutation common in non-Jewish Tay-Sachs disease: frequency and RNA studies.Hum Mutat. 1992;1(4):303-9. doi: 10.1002/humu.1380010407. Hum Mutat. 1992. PMID: 1301938
-
Prenatal diagnosis of a Japanese family at risk for Tay-Sachs disease. Application of a fluorescent competitive allele-specific polymerase chain reaction (PCR) method.Kobe J Med Sci. 1999 Dec;45(6):259-70. Kobe J Med Sci. 1999. PMID: 10985159
-
Heterozygote screening for Tay-Sachs disease: past successes and future challenges.Curr Opin Pediatr. 1996 Dec;8(6):625-9. doi: 10.1097/00008480-199612000-00014. Curr Opin Pediatr. 1996. PMID: 9018448 Review.
Cited by
-
Reference Data on Neonatal Serum N-Acetyl-β-hexosaminidase Activity.Dis Markers. 2018 Jul 2;2018:6187245. doi: 10.1155/2018/6187245. eCollection 2018. Dis Markers. 2018. PMID: 30057650 Free PMC article.
-
Astroglial vesicular network: evolutionary trends, physiology and pathophysiology.Acta Physiol (Oxf). 2018 Feb;222(2):10.1111/apha.12915. doi: 10.1111/apha.12915. Epub 2017 Aug 3. Acta Physiol (Oxf). 2018. PMID: 28665546 Free PMC article. Review.
-
Hexosaminidase assays.Glycoconj J. 2009 Nov;26(8):945-52. doi: 10.1007/s10719-008-9137-5. Glycoconj J. 2009. PMID: 18473163
-
Knowledge and attitudes toward a free education and Ashkenazi Jewish carrier testing program.J Genet Couns. 2006 Feb;15(1):61-70. doi: 10.1007/s10897-005-9004-5. J Genet Couns. 2006. PMID: 16468087
-
Novel mutations and DNA-based screening in non-Jewish carriers of Tay-Sachs disease.Am J Hum Genet. 1997 May;60(5):1099-106. Am J Hum Genet. 1997. PMID: 9150157 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical